New England Capital Financial Advisors »

Heron Therapeutics shares owned by New England Capital Financial Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by New England Capital Financial Advisors from 13F filings

Historical chart of New England Capital Financial Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by New England Capital Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by New England Capital Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3k 475 2.77
2023-12-31 $808 475 1.70
2023-09-30 $490 475 1.03
2023-06-30 $551 475 1.16
2023-03-31 $718 475 1.51
2022-12-31 $1.4k 475 2.95

More positions owned by New England Capital Financial Advisors

Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Capital Grp Fixed Incm Etf T Municipal Income (CGMU)
Spdr Ser Tr Bloomberg Invt (FLRN)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)

View all positions for New England Capital Financial Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
OrbiMed Advisors
Vanguard Group
BlackRock
Velan Capital Investment Management
Franklin Resources
Tejara Capital
Palisade Capital Management
Millennium Management
Adage Capital Partners GP
Geode Capital Management
Clearline Capital
D. E. Shaw & Co
JW Asset Management
Orchard Capital Managment

View all funds holding Heron Therapeutics